A Study of Acalabrutinib in Combination With Rituximab Versus Ibrutinib Versus Acalabrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Clinical trial NCT02735876 · WITHDRAWN
Trial details
- NCT number
- NCT02735876
- Sponsor
- Acerta Pharma BV
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2020-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.